Thuy-Nhien Nguyen

TL;DR: A new release of curated genome variation data on 7,000 Plasmodium falciparum samples from MalariaGEN partner studies in 28 malaria-endemic countries aims to facilitate research into the evolutionary processes affecting malaria control and to accelerate development of the surveillance toolkit required for malaria elimination.

TL;DR: Persistent largely asymptomatic P vivax and P falciparum infections are common in this area of low seasonal malaria transmission and infections with low-density parasitaemias can develop into much higher density infections at a later time, which are likely to sustain malaria endemicity.

TL;DR: The results suggest that, if used as part of a comprehensive, well-organised, and well-resourced elimination programme, dihydroartemisinin-piperaquine MDA can be a useful additional tool to accelerate malaria elimination.

TL;DR: A quantitative survey of the villagers’ perceptions was undertaken in Vietnam to explore why some people participate in MDAs and others do not, and suggests several approaches to increase participation in mass drug administration campaigns.

TL;DR: This work focused on uPCR-detected Plasmodium infections from a recent cluster randomized trial aimed at interrupting malaria transmission through mass drug administrations and found a high variability in ICCs and hence sample size requirements between study sites was observed.